27.06.2013 Views

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

tel-00827710, version 1 - 29 May 2013<br />

III. COMBINATION OF ANTIGEN WITH ADJUVANT<br />

A. The timing of adjuvant <strong>de</strong>livery should be coordinated with<br />

antigen processing and presentation<br />

1) Effects of poly I:C and type I IFN in our mo<strong>de</strong>l<br />

Adjuvants and more specifically type I IFN can impact CD8 + T cell cross-priming in a vari<strong>et</strong>y<br />

of ways. In our specific mo<strong>de</strong>l we <strong>de</strong>monstrated that the optimal timing of adjuvant <strong>de</strong>livery<br />

is immunization route-<strong>de</strong>pen<strong>de</strong>nt (Figure 37). Moreover, for the optimal benefit,<br />

administration should be closely coordinated with the timing of antigen uptake and<br />

presentation, as <strong>de</strong>livery that occured too early inhibited subsequent priming while late<br />

<strong>de</strong>livery enhanced it (Figure 38). These effects of poly I:C were shown to be type I IFN-<br />

<strong>de</strong>pen<strong>de</strong>nt (Figures 41 and 46). Specifically, we observed that poly I:C and type I IFN act at<br />

several levels. From these results, we propose a mo<strong>de</strong>l for adjuvant action and timing of<br />

<strong>de</strong>livery that illustrates how these diverse effects can impact cross-priming, based on the<br />

kin<strong>et</strong>ic of antigen uptake, processing and presentation in both a positive or negative fashion.<br />

Figure 52 recapitulates these points in different experimental conditions: (A) absence of<br />

adjuvant, (B) early adjuvant <strong>de</strong>livery, (C) late adjuvant <strong>de</strong>livery.<br />

In our mo<strong>de</strong>l of immunization with cell-associated antigen, in combination with poly I:C<br />

adjuvant <strong>de</strong>livery, we observed:<br />

- A substantial recruitment of DCs into the draining lymph no<strong>de</strong> (Figure 43A). If<br />

these cells have already phagocytosed antigen, this recruitment can be consi<strong>de</strong>red<br />

to have a positive effect for cross-priming, as it may increase the amount of<br />

antigen reaching the draining lymph no<strong>de</strong>. In contrast, if antigen has not y<strong>et</strong> been<br />

engulfed, then this flow of DCs to lymph no<strong>de</strong> results in the removal of them from<br />

the skin, ren<strong>de</strong>ring them no longer capable of phagocytosing antigen (Figure 52,<br />

(1)).<br />

- In parallel, poly I:C treatment induced DC maturation (Figure 43B). Again, this<br />

process will potentiate cross-priming if the antigen has already been phagocytosed,<br />

by improving the ability of DCs to activate T cells. However, if these maturation<br />

signals arrive before antigen engulfment, DC maturation would lead to<br />

downregulation of antigen capture ability and inhibition of cross-presentation<br />

(Figure 52, (2)).<br />

- We observed the disappearance of CD8α + DCs upon poly I:C stimulation (Figures<br />

43 and 44), which may be due to <strong>de</strong>ath of this cell subs<strong>et</strong>. As these cells are<br />

154

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!